Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. - Wikidata - wikimedia - TriplyDB

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

http://www.wikidata.org/entity/Q30881058

about

Practical approach to medical management of glaucoma Brimonidine in the treatment of glaucoma and ocular hypertension Hearing in older adults with exfoliation syndrome/exfoliation glaucoma or primary open-angle glaucoma Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma Combination medical treatment for primary open angle glaucoma and ocular hypertension: a network meta-analysis Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma Neuroprotection for treatment of glaucoma in adults Cyclodestructive procedures for glaucoma Combined surgery versus staged surgery for eyes with cataract and glaucoma Neuroprotection for treatment of glaucoma in adults Interventions for improving adherence to ocular hypotensive therapy Laser trabeculoplasty for open angle glaucoma Interventions for improving adherence to ocular hypotensive therapy Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy Cyclodestructive procedures for refractory glaucoma Amyloidosis in Retinal Neurodegenerative Diseases Systemic and Ocular Hemodynamic Risk Factors in Glaucoma The significance of intraocular pressure elevation during sleep-related postures Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus Critical pathogenic events underlying progression of neurodegeneration in glaucoma Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma Comparison of Treated Mean Intraocular Pressure in Stable Glaucoma with Different Severity in Vietnam Current status of epibulbar anti-glaucoma drainage devices in glaucoma surgery The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey A Mutation in LTBP2 Causes Congenital Glaucoma in Domestic Cats (Felis catus)Gaps in Glaucoma care: A systematic review of monoscopic disc photos to screen for glaucoma Update in intracranial pressure evaluation methods and translaminar pressure gradient role in glaucoma.Medical Management of Glaucoma in the 21st Century from a Canadian Perspective Critical evaluation of latanoprostene bunod in the treatment of glaucoma Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study Neuroprotection for treatment of glaucoma in adults.The difference in translaminar pressure gradient and neuroretinal rim area in glaucoma and healthy subjects Intraocular pressure fluctuations in professional brass and woodwind musicians during common playing conditions.Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015 Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data.Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency.Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data.Central corneal thickness and progression of the visual field and optic disc in glaucoma.

P2860

Q22305449-E111E970-09E3-42D6-9E5D-79EBF80ECCA1 Q22305848-0872D8E0-0267-4D26-97ED-23A76EE4A27A Q23913070-140EC9BC-F042-4563-9969-CDF935B6EA83 Q24186450-94946271-1624-4484-A7BE-126D34BED7C7 Q24192958-985F2880-9607-45D0-8CF3-E806CC5FC773 Q24194899-AB68DE0E-DC9B-41D5-BCC3-07791F4F2646 Q24200657-20D86BE6-DE5E-41EA-9102-FF8662597DBB Q24234611-6AC010AA-3B52-4F8D-B55B-3B6E5BB280F7 Q24235707-6CF4C7CA-F19D-4CA8-A7AC-546BF595ABE0 Q24240024-E7B942FF-9CBF-47C4-94FC-22E2C37F1075 Q24241641-B6FF61E2-B5AF-4C30-BB5A-A4ABF569A494 Q24242939-6E315A34-A581-4091-90E7-FD136120DC8A Q24245942-0C80E5BA-2F51-42D6-A245-CA8032D09ADA Q24338381-21BEE771-3DCE-44EB-A0CC-0A162D70F591 Q26471740-78178E14-ABC7-462D-9D70-5274F6CF7061 Q26739839-B08B8112-09C0-4BBD-A51F-F16270C7CBCB Q26777829-9D2D53A5-E477-4157-9964-D1687A30B45E Q26825794-F5C1D048-3BD9-43DD-A2C1-E030D43B6F3B Q26830201-6314EB8A-B14E-4B91-8D65-4B3BB859012C Q26859194-AE8ABF20-7296-49C0-9C08-294A6BDEC94B Q26861763-0023D8E5-38F2-4D0B-B48D-992470E0CF62 Q27002667-0CD935B2-9042-4198-8073-1C919985EB05 Q27024617-BB146DE2-F408-47A3-B955-3D1EAE9B7B79 Q27304716-721E8FA2-9292-45CE-A4CD-BD9DC3F30911 Q27312146-FEB89AD6-6123-4E3E-BEDA-2411FEB7A1DB Q27345105-1105909C-B122-4A72-840B-4DAA335E817A Q27687604-14379471-43E5-4C6C-89C0-EED8A33ABB3E Q28074316-E2828E16-4C37-4573-83AB-DA90906D20DE Q28077208-CB92D69D-C26F-4199-BA9B-BBE3C0F3C1C0 Q28548224-4EB24626-2CB7-44D5-B75C-BAABA47AE3F7 Q30238789-1D71EC12-18D7-4F0A-A8B3-25621979625F Q30437810-6CAE75C0-E591-40DD-88F9-09D63B60C3E1 Q30552848-B331A643-E5C2-43C0-B01E-543A3DE823DE Q30749049-02E6D44C-2978-47F1-B9A0-8656D8A314F6 Q30789570-007DA47C-B57B-4FDF-A73C-6B1AE3B63BCF Q30882123-C2ED2AD4-4BEC-46C1-A6F0-A57BEE89D9F9 Q30890274-7B23300D-6E18-4941-8B34-2287747F0BAA Q30990445-BD39FC03-B3D0-4B56-9E19-09EA2BD14D51 Q31141723-85A6051B-4FCE-4528-B794-660AFCA8C959 Q33219713-79442A9B-E629-40CB-9B20-440D25B19BED

P2860

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

http://www.wikidata.org/entity/Q30881058

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Factors for glaucoma progressi ...... early manifest glaucoma trial.

@ast

Factors for glaucoma progressi ...... early manifest glaucoma trial.

@en

type

label

Factors for glaucoma progressi ...... early manifest glaucoma trial.

@ast

Factors for glaucoma progressi ...... early manifest glaucoma trial.

@en

prefLabel

Factors for glaucoma progressi ...... early manifest glaucoma trial.

@ast

Factors for glaucoma progressi ...... early manifest glaucoma trial.

@en

P1433

Q30881058-74D44E55-694A-4989-A6C3-0C39B9C4FB16

P1476

Q30881058-E24B844C-70C9-437D-A5F6-E24A6ACF3CD3

P2093

Q30881058-3C1DC3C4-CC0D-4A2A-A38D-873EE22043FE

Q30881058-8238C4A6-270E-4260-82DB-50FB89BBD75F

Q30881058-AE8109ED-4FB3-4A8E-AF62-DBBEC4380AEC

Q30881058-AE988F04-9B31-4F83-9A2E-220AE60C118B

Q30881058-C2CA802F-204B-4872-8CAC-D2E98B50D221

Q30881058-C6276FDD-D064-4C1B-BF3D-1E4600FB786D

Q30881058-E034E1CF-28CD-46CA-9199-D6670FD97B2B

P304

Q30881058-EB5A3D74-10F3-42E9-BF54-D7C09B1D0E8C

P31

Q30881058-47F647BB-1BAA-4CA2-A35C-78BBEB911B1D

P356

Q30881058-9AB5D143-84B3-4AAB-8ABB-93D50373D8F7

P407

Q30881058-DAD8633E-5F10-4ECF-AB4C-B97C52056735

P433

Q30881058-475F418F-5D93-4192-A0A6-9CD7D3FC25AD

P478

Q30881058-F1FAFAF2-8A36-42FD-B18F-31A4883C2183

P577

Q30881058-A243609B-70A8-4ECA-8826-B77FA4CA5222

P698

Q30881058-2BDCD8E9-A2CF-4D75-B7B8-1ED03867FAD8

P356

ARCHOPHT.121.1.48

P1433

JAMA Ophthalmology

P1476

Factors for glaucoma progressi ...... early manifest glaucoma trial.

@en

P2093

Anders Heijl

http://www.w3.org/2001/XMLSchema#string

Bo Bengtsson

http://www.w3.org/2001/XMLSchema#string

Early Manifest Glaucoma Trial Group

http://www.w3.org/2001/XMLSchema#string

Eugene Komaroff

http://www.w3.org/2001/XMLSchema#string

Leslie Hyman

http://www.w3.org/2001/XMLSchema#string

M Cristina Leske

http://www.w3.org/2001/XMLSchema#string

Mohamed Hussein

http://www.w3.org/2001/XMLSchema#string

P304

48-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHT.121.1.48

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12523884

http://www.w3.org/2001/XMLSchema#string